Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Goadsby

Showing results (741-750 of 916) with videos related to

Pageof 92
Sort By:
The Journal of Headache and Pain|December 2, 2022
Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER studyPiero Barbanti, Peter J Goadsby, Giorgio Lambru, et al.
European Journal of Neurology|December 30, 2022
Eptinezumab improved patient-reported outcomes and quality of life in patients with migraine and prior preventive treatment failuresPeter J Goadsby, Piero Barbanti, Giorgio Lambru, et al.
Cephalalgia : an International Journal of Headache|March 27, 2007
Treatment-emergent CNS symptoms following triptan therapy are part of the attackP J Goadsby, D W Dodick, M Almas, et al.
Current Pain and Headache Reports|October 29, 2004
Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR ProjectDavid W Dodick, Richard B Lipton, Michel D Ferrari, et al.
Cephalalgia : an International Journal of Headache|June 1, 2010
Phenotype of patients responsive to occipital nerve stimulation for refractory head painK Paemeleire, J-P Van Buyten, M Van Buynder, et al.
Headache|October 27, 2025
Evaluating associations of migraine-related vertigoNazia Karsan, Nicolas Vandenbussche, Robyn Jenia-Wilcha, et al.
Clinical Therapeutics|November 9, 2004
Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project)F Michael Cutrer, Peter J Goadsby, Michel D Ferrari, et al.
Neurobiology of Disease|July 21, 2004
Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: a Fos studyLaura Benjamin, Miles J Levy, Michele P Lasalandra, et al.
Brain : a Journal of Neurology|August 19, 2020
Differential medication overuse risk of novel anti-migraine therapeuticsChonlawan Saengjaroentham, Lauren C Strother, Isaac Dripps, et al.
Brain : a Journal of Neurology|February 12, 2005
A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrateS K Afridi, M S Matharu, L Lee, et al.
Pageof 92

Showing results (741-750 of 916) with videos related to

Sort By:
Pageof 92
The Journal of Headache and Pain|December 2, 2022
Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER studyPiero Barbanti, Peter J Goadsby, Giorgio Lambru, et al.
European Journal of Neurology|December 30, 2022
Eptinezumab improved patient-reported outcomes and quality of life in patients with migraine and prior preventive treatment failuresPeter J Goadsby, Piero Barbanti, Giorgio Lambru, et al.
Cephalalgia : an International Journal of Headache|March 27, 2007
Treatment-emergent CNS symptoms following triptan therapy are part of the attackP J Goadsby, D W Dodick, M Almas, et al.
Current Pain and Headache Reports|October 29, 2004
Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR ProjectDavid W Dodick, Richard B Lipton, Michel D Ferrari, et al.
Cephalalgia : an International Journal of Headache|June 1, 2010
Phenotype of patients responsive to occipital nerve stimulation for refractory head painK Paemeleire, J-P Van Buyten, M Van Buynder, et al.
Headache|October 27, 2025
Evaluating associations of migraine-related vertigoNazia Karsan, Nicolas Vandenbussche, Robyn Jenia-Wilcha, et al.
Clinical Therapeutics|November 9, 2004
Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project)F Michael Cutrer, Peter J Goadsby, Michel D Ferrari, et al.
Neurobiology of Disease|July 21, 2004
Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: a Fos studyLaura Benjamin, Miles J Levy, Michele P Lasalandra, et al.
Brain : a Journal of Neurology|August 19, 2020
Differential medication overuse risk of novel anti-migraine therapeuticsChonlawan Saengjaroentham, Lauren C Strother, Isaac Dripps, et al.
Brain : a Journal of Neurology|February 12, 2005
A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrateS K Afridi, M S Matharu, L Lee, et al.
Pageof 92